Tag: # Chronic

Introduction: Diabetic kidney disease (DKD) remains a leading cause of end-stage renal failure worldwide, contributing significantly to morbidity and mortality in individuals with Type 2 Diabetes Mellitus (T2D). Recent advancements highlight the potential of sodium-glucose cotransporter-2 (SGLT2) inhibitors as a groundbreaking therapeutic approach. These drugs not only regulate blood glucose levels but also provide nephroprotective…